Pricing

Log inSign up
‌

Cour Pharmaceuticals Development

42 people · 0 jobs
‌

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Industries

Biotechnology, Pharmaceutical

Headquarters

Elmhurst, United States

Employees

11-50

Links


Org chart

John J. Puisis
Co-Founder & President & CEO
Collapse
Brian C. Bock
CFO
Sarah Longoria
Chief People Officer
Robert Hodge
VP of Technical Development
SR
Stan Russell
Vice President Of Quality

Board & advisors

Kari Nadeau
Advisor
Ciarán P. Kelly
Advisor
John Fung
Advisor
M. Eric Gershwin
Advisor
Stephen D. Miller
Advisor
Lonnie D. Shea
Advisor

Teams

+8

Advisory and Executive Roles

12 people · 0 jobs

IK
JG
+6

Research and Development

10 people · 0 jobs

+3

Leadership Team

7 people · 0 jobs

Finance and Accounting

3 people · 0 jobs

BL
PA

Regulatory Affairs and Compliance

3 people · 0 jobs


Offices

  • HQ

    21 people · 0 jobs

    TW
    +17

Similar companies

Amgen

302 followers

Tango Therapeutics

3 followers

Arthritis Knee Pain Centers

2 followers

AbbVie

294 followers

Cellares

5 followers

Elanco

28 followers

AtriCure

4 followers

Abbott

406 followers

Bristol-Myers Squibb

275 followers

Gilead Sciences

171 followers

Regeneron

144 followers

Explore companies

Company
AboutContactBlog
Product
LearnExploreIterate
Business
SolutionsTrustPricing
Enrich
Browser ExtensionCRM EnrichmentDeveloper Portal
Social
© 2025 Orgio, Inc.
Terms
Privacy
Do not sell my info